BIA400 versus Ponto Wide: a long-term retrospective analysis of implant stability, tolerability and survival in bone conduction devices
- 1Otorhinolaryngology, Deventer Hospital, Netherlands
Abstract
Objective: The purpose of this single-centre retrospective study was to determine the long-term outcomes of the BIA400 and Ponto Wide, in terms of implant stability, soft tissue reactions, skin thickening and implant loss.
Methods: Adults who had the BIA400 or Ponto Wide implanted between January 2013 and December 2023 and had at least two follow-up appointments were included, leading to a cohort of 93 BIA400 and 114 Ponto Wide implants.
Results: Significantly more soft tissue reactions with a Holgers Scale score of 1 or greater (p = 0.003), adverse soft tissue reactions of Holgers Scale score of 2 or greater (p = 0.018), skin thickening (p < 0.001) and skin thickening requiring treatment (p ≤ 0.001) occurred in the BIA400 group. No difference in implant stability was found. One BIA400 implant (1.1 per cent) and three Ponto Wide implants (2.7 per cent) were lost.
Conclusion: Both implants have excellent implant stability and similar implant survival rates. The Ponto Wide has favourable outcomes in terms of (adverse) soft tissue reaction and skin thickening (requiring treatment).
Related
- Clinical Performance and Survival Outcomes of All-on-4 Full-Arch Implant-Supported Prostheses in Patients With a Completely Edentulous Arch: A Retrospective Cohort Study
- Baseline Predictors of Crestal Bone Maintenance and Implant Stability Following Immediate Implant Placement With Platelet-Rich Fibrin: A Retrospective Observational Study.
- Incidence of Osteoradionecrosis and Dental Implant Survival in Patients With Irradiated Head and Neck Malignancies: A Systematic Review and Meta-Analysis
- Navigation-Assisted and Robotic Total Hip, Knee, and Unicompartmental Arthroplasty: Reconciling Positioning Accuracy with Biomaterial Performance and Long-Term Implant Survival.
- Long-term implant integrity and complications after risk-reducing mastectomy with immediate implant reconstruction: a retrospective cohort study with prospective ultrasound follow-up at a Swedish university hospital
BibTeX
@article{haan2026bia400,
title = {{BIA400 versus Ponto Wide: a long-term retrospective analysis of implant stability, tolerability and survival in bone conduction devices}},
author = {Florine de Haan and Jeroen Peters and Pauline van Kempen and Ruben Strijbos and Steven Bom},
journal = {The Journal of Laryngology and Otology},
year = {2026},
month = nov,
doi = {10.1017/s0022215126105027},
url = {https://doi.org/10.1017/s0022215126105027},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - BIA400 versus Ponto Wide: a long-term retrospective analysis of implant stability, tolerability and survival in bone conduction devices
AU - Florine de Haan
AU - Jeroen Peters
AU - Pauline van Kempen
AU - Ruben Strijbos
AU - Steven Bom
PY - 2026
DA - 2026/11/06
JO - The Journal of Laryngology and Otology
DO - 10.1017/s0022215126105027
UR - https://doi.org/10.1017/s0022215126105027
AB - Objective: The purpose of this single-centre retrospective study was to determine the long-term outcomes of the BIA400 and Ponto Wide, in terms of implant stability, soft tissue reactions, skin thickening and implant loss. Methods: Adults who had the BIA400 or Ponto Wide implanted between January 2013 and December 2023 and had at least two follow-up appointments were included, leading to a cohort of 93 BIA400 and 114 Ponto Wide implants. Results: Significantly more soft tissue reactions with a Holgers Scale score of 1 or greater (p = 0.003), adverse soft tissue reactions of Holgers Scale score of 2 or greater (p = 0.018), skin thickening (p < 0.001) and skin thickening requiring treatment (p ≤ 0.001) occurred in the BIA400 group. No difference in implant stability was found. One BIA400 implant (1.1 per cent) and three Ponto Wide implants (2.7 per cent) were lost. Conclusion: Both implants have excellent implant stability and similar implant survival rates. The Ponto Wide has favourable outcomes in terms of (adverse) soft tissue reaction and skin thickening (requiring treatment).
SN - 0022-2151
SN - 1748-5460
ER -